Magnetic resonance imaging contrast agents comprising zinc-containing magnetic metal oxide nanoparticles

The present invention relates to an MRI contrast agent that includes zinc-containing water-soluble metal oxide nanoparticles and has an improved contrast effect. The zinc-containing water-soluble metal oxide nanoparticles are characterized by addition of zinc to a matrix comprising the metal oxide n...

Full description

Saved in:
Bibliographic Details
Main Authors CHEON JINWOO, JUN YOUNG-WOOK, JANG JUNG-TAK
Format Patent
LanguageEnglish
Published 28.06.2016
Subjects
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to an MRI contrast agent that includes zinc-containing water-soluble metal oxide nanoparticles and has an improved contrast effect. The zinc-containing water-soluble metal oxide nanoparticles are characterized by addition of zinc to a matrix comprising the metal oxide nanoparticles or by substitution of metal in the matrix, resulting in the improved contrast effect of MRI. In addition, the zinc-containing metal oxide nanoparticles of the present invention include the MRI contrast agent t having hybrid structures of "zinc-containing metal oxide nanoparticle-biologically/chemically active material" in which the nanoparticle is conjugated with a bioactive material such as proteins, antibodies, and chemical materials.
Bibliography:Application Number: US20080527482